A venture capital and private equity firm commercializing discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development.
In August 2018, OS Fund announced the $250m OS Fund II. OS Fund II invested in 12 portfolio companies for a total of $24.9 million. Investments include Arzeda, NuMat TechnologiesNuMat Technologies, and UBiome.